Ever Fortune.AI Co., Ltd. (TPEX:6841)
Taiwan · Delayed Price · Currency is TWD 65.10
-1.00 (-1.51%)
Nov 4, 2025, 1:30 PM CST
Ever Fortune.AI Revenue
Ever Fortune.AI had revenue of 91.24M TWD in the quarter ending June 30, 2025, with 0.29% growth. This brings the company's revenue in the last twelve months to 354.95M, up 67.47% year-over-year. In the year 2024, Ever Fortune.AI had annual revenue of 337.52M with 259.13% growth.
Revenue (ttm)
354.95M
Revenue Growth
+67.47%
P/S Ratio
17.58
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 337.52M | 243.54M | 259.13% |
| Dec 31, 2023 | 93.98M | 40.08M | 74.35% |
| Dec 31, 2022 | 53.90M | 15.66M | 40.94% |
| Dec 31, 2021 | 38.24M | 34.76M | 996.76% |
| Dec 31, 2020 | 3.49M | 2.29M | 190.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |